TRINITY BIOTECH PLC's ticker is TRIB and the CUSIP is 896438306. A total of 21 filers reported holding TRINITY BIOTECH PLC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,707 | -24.6% | 27,062 | 0.0% | 0.00% | – |
| Q2 2023 | $26,120 | +2.7% | 27,062 | 0.0% | 0.00% | – |
| Q1 2023 | $25,438 | -5.1% | 27,062 | 0.0% | 0.00% | – |
| Q4 2022 | $26,791 | -7.6% | 27,062 | 0.0% | 0.00% | – |
| Q3 2022 | $29,000 | -12.1% | 27,062 | 0.0% | 0.00% | – |
| Q2 2022 | $33,000 | +13.8% | 27,062 | 0.0% | 0.00% | – |
| Q1 2022 | $29,000 | -25.6% | 27,062 | 0.0% | 0.00% | – |
| Q4 2021 | $39,000 | -32.8% | 27,062 | 0.0% | 0.00% | – |
| Q3 2021 | $58,000 | -27.5% | 27,062 | 0.0% | 0.00% | – |
| Q2 2021 | $80,000 | -21.6% | 27,062 | 0.0% | 0.00% | – |
| Q1 2021 | $102,000 | – | 27,062 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACK Asset Management | 928,000 | $10,616,000 | 4.44% |
| GOLDMAN CAPITAL MANAGEMENT INC | 350,961 | $4,015,000 | 2.86% |
| Paradice Investment Management LLC | 992,235 | $11,351,000 | 2.07% |
| Centaur Capital | 77,500 | $887,000 | 1.33% |
| Adirondack Funds | 302,305 | $3,458,000 | 1.33% |
| Adirondack Research & Management Inc. | 302,305 | $3,458,000 | 1.33% |
| RK Capital | 565,472 | $6,469,000 | 1.18% |
| Lyon Street Capital, LLC | 140,943 | $1,612,000 | 1.17% |
| Benchmark Capital Advisors | 89,941 | $1,029,000 | 0.84% |
| KEANE CAPITAL MANAGEMENT INC | 55,045 | $630,000 | 0.83% |